Fudan University: all 1,308 studies
Page 6 of 14. Open to participants first (637), then studies with results posted, then the rest; newest registration first within each.
- Long-term Prognosis for Non-functional Neuroendocrine Tumors of the Pancreatic Body and Tail ≤ 3cmRecruitingNCT05907824
- Endostar Plus Toripalimab as Adjuvant Therapy for Resectable Stage III-Oligometastatic Stage IV Cutaneous MelanomaRecruitingNCT05907512Phase 2
- Circulating Tumor DNA Methylation Guided Postoperative Follow-up Strategy for Non-metastatic Colorectal CancerRecruitingNCT05904665Not applicable
- TCb vs EC-T in High Risk ER+/HER2- Breast CancerRecruitingNCT05901428Phase 3
- Cryoablation Combined With Tislelizumab Plus Lenvatinib in 1L Treatment of Advanced HCC (CASTLE-10)RecruitingNCT05897268Phase 2
- Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)RecruitingNCT05893056Phase 2
- The Clinical Value of an Artificial Intelligence System Using Abbreviated Protocol of Breast MRI Facilitates Classification of Breast LessionsNot yet recruitingNCT05892380
- Efficacy and Safety of Fluzoparib Combined With Adjuvant Endocrine Therapy for HR+/HER2- SNF3-subtype Early Breast Cancer (BCTOP-L-A01)RecruitingNCT05891093Phase 3
- A Randomized, Controlled, Open-label Clinical Trial of Adjuvant Intensive Therapy for HR+/ HER2-SNF4 Early Breast CancerNot yet recruitingNCT05889871Phase 3
- EC-THP Versus TCbHP in HER2-positive Lymph Node Positive Early Breast CancerRecruitingNCT05883852Phase 3
- Anatomical Resection VS. Nonanatomical Resection for Colorectal Liver Metastases With Gene Mutation or Right-sidednessNot yet recruitingNCT05881746Not applicable
- Randomized Controlled Clinical Study on the Reduction of Tumor Marker Levels in Breast Cancer Patients by Huaier GranulesNot yet recruitingNCT05871437Phase 4
- Tislelizumab Combing Chemoradiotherapy in Recurrent Cervical CancerRecruitingNCT05863260
- A Multi-center, Randomized, Open-label, Phase III Study Comparing PD-1 Inhibitor Combined With Antivascular Therapy and Anthracycline/Taxane-based Adjuvant Chemotherapy Versus Anthracycline/Taxane-based Adjuvant Chemotherapy Alone in Patients With Operable Triple-negative Breast CancerRecruitingNCT05862064Phase 3
- Adjuvant Pyrotinib and Capecitabine For HER2 Positive Micro Invasive Breast CancerRecruitingNCT05861271Phase 2
- Clinical Study of Huaier Granules in Patients With Advanced Breast Cancer Without Visceral MetastasisNot yet recruitingNCT05860907Phase 4
- Postoperative Effects of Different Enterostomy ApproachesRecruitingNCT05853094Not applicable
- Plasma cfDNA Fragmentomics for Early pNET Detection and Differential Diagnosis of Solid Pancreatic TumorsRecruitingNCT05847855
- Adjuvant Study of Pyrotinib in Combination With Trastuzumab in HER2 Positive Invasive Breast CancerNot yet recruitingNCT05841381Phase 3
- The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue SarcomaRecruitingNCT05839275Phase 1/2
- Cryoablation Combined With Sintilimab Plus Lenvatinib in 1L Treatment of Advanced ICC (CASTLE-ICC-Chemo-free)RecruitingNCT05835245Phase 2
- Oncolytic Virotherapy Combined With Tislelizumab Plus Lenvatinib in Patients With Advanced Biliary Tract Cancer (OPTIONS-05)RecruitingNCT05823987Phase 2
- Precise Treatment for BLIS Subtype of TNBC in the First-line Treatment of Locally Advanced or Metastatic Breast CancerRecruitingNCT05806060Phase 3
- Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1016)RecruitingNCT05794724
- Intraoperative Frozen Section Pathology to Guide Surgical Treatment for Lung Adenocarcinoma (ECTOP-1015)RecruitingNCT05794711
- Cryoablation Combined With Sintilimab Plus Lenvatinib in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Biliary Tract Cancer （CASTLE-08）RecruitingNCT05781074Phase 2
- The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue SarcomaRecruitingNCT05774275Phase 1/2
- Intensified Treatments for Patients With Locally Advanced Nasopharyngeal Carcinoma With Detectable EBV DNA After One Cycle GP Regime Neoadjuvant ChemotherapyRecruitingNCT05772208Phase 3
- Vitamin E Combined With Fruquintinib and Tislelizumab in Microsatellite Stabilized Metastatic Colorectal Cancer PatientsRecruitingNCT05771181Phase 2
- Effect of Hepatectomy on the Prognosis of Patients With Nasopharyngeal Carcinoma Liver MetastasesRecruitingNCT05771025Not applicable
- A Study of IO Plus Radiotherapy in Patients With Advanced ESCC.RecruitingNCT05760391Not applicable
- Famitinib in Combination With Camrelizumab and TPC in The First-line Treatment of Immunomodulatory Locally Advanced or Metastatic TNBC.RecruitingNCT05760378Phase 3
- PARP Inhibitor With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2-Advanced Breast CancerRecruitingNCT05759546Phase 2
- FUSCC Refractory TNBC Platform Study (FUTURE2.0)RecruitingNCT05749588Phase 2
- Cohort of Twin Pregnancy and the OffspringRecruitingNCT05727085
- Segmentectomy for Ground Glass-dominant Invasive Lung Cancer (ECTOP-1012)RecruitingNCT05717803Phase 3
- Maximal Cytoreductive Therapies on Post-treatment Metastases in Pts With mHSPC During Apalutamide Plus ADT TreatmentNot yet recruitingNCT05717582Phase 2
- Application of "Heidelberg Triangle" Dissection in Pancreatoduodenectomy and Distal PancreatectomyRecruitingNCT05703581
- Oncolytic Virotherapy Plus PD-1 Inhibitor and Lenvatinib as Second-line or Later Therapy in Patients With Advanced Hepatocellular CarcinomaRecruitingNCT05675462Phase 1
- Radiotherapy Alone Versus Concurrent Chemo-radiotherapy for Nasopharyngeal Carcincoma Patients With Undectable EBV DNA After One Cylce Neoadjuvant ChemotherpyRecruitingNCT05674305Phase 3
- GEMOX Combined With Donafenib and Tislelizumab in Advanced Biliary Tract CarcinomaRecruitingNCT05668884Phase 2
- A Multicenter Registry Study on Stage III Hepatocellular Carcinoma in Unresectable CNLC Liver CancerNot yet recruitingNCT05660213
- Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal CancerNot yet recruitingNCT05645094
- Predictive Value of ctDNA for NED Status in mCRC and Its Utility in Guiding Therapeutic InterventionRecruitingNCT05635630Not applicable
- The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal CancerNot yet recruitingNCT05634590Phase 2
- Modulation Therapy for Locally Advanced NPC Based on Plasma EBV DNA Level Post-ICTRecruitingNCT05628922Phase 2
- The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal CancerRecruitingNCT05628038Phase 2
- SNF Platform Study of HR+/ HER2-advanced Breast CancerRecruitingNCT05594095Phase 2
- Clinical Study on the EBV CAR-T /TCR-T Cells in the Treatment of Nasopharyngeal CarcinomaRecruitingNCT05587543Early Phase 1
- Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant TherapyRecruitingNCT05582499Phase 2
- Exploring Whether Disease-free Intervals Can Guide Endocrine Combined Targeted Therapy for ER+/HER2+ Advanced Breast Cancer (T-sunflower)Not yet recruitingNCT05577923Phase 2
- Novel Therapy Target in Metastatic Prostate CancerRecruitingNCT05577689
- GQ1001 Combined With Pyrotinib for Treatment With HER2 Positive Metastatic Breast CancerRecruitingNCT05575804Phase 1/2
- An Open Labeled RCT on the Effect of Additional hCG Injection for LPS on Pregnancy Outcomes in IHH PatientsRecruitingNCT05569577Not applicable
- The Efficacy and Safety of Fruquintinib Plus Chemotherapy as Second-line Treatment in Metastatic Colorectal CancerRecruitingNCT05555901Phase 2
- The Combination of Immunotherapy and Neoadjuvant Short-course Radiotherapy in Early Rectal CancerRecruitingNCT05555888Phase 2
- Laparoscopic vs Open Total Gastrectomy for Gastric CancerRecruitingNCT05537129Not applicable
- Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap ReconstructionRecruitingNCT05512286Not applicable
- PD-1 Inhibitors With or Without Radiation in Advanced MelanomaNot yet recruitingNCT05498805Phase 2
- Chemotherapy vs Chemoradiotherapy for Post-operative Endometrial Cancer Patients With P53-mutationNot yet recruitingNCT05489848Phase 2/3
- Neoadjuvant Radiation in Locally Advanced Breast CancerRecruitingNCT05479409Phase 2
- Study of C-TIL052A Cell Therapy in Advanced Cervical CancerRecruitingNCT05475847Phase 1
- Fruquintinib Plus Capecitabine Versus Capecitabine as Maintenance Therapy for Metastatic Colorectal Cancer After First-line ChemotherapyNot yet recruitingNCT05451719Phase 2
- Bespoke ctDNA Assay for Recurrence and Treatment Response Monitoring in Advanced Epithelial Ovarian CancerRecruitingNCT05446545
- Value of Pleural Lavage Cytology in Resectable Esophageal Carcinoma Eastern Cooperative Thoracic Oncology Projects 2005, ECTOP-2005)RecruitingNCT05443841
- Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before HepatectomyRecruitingNCT05442632Phase 2
- Induction Chemotherapy and Toripalimab Followed by Radiotherapy in Unresectable Laryngeal/Hypopharyngeal CarcinomaRecruitingNCT05420597Phase 2
- A Combination Therapy Including Anti-PD-1 Immunotherapy in MSS Rectal Cancer With Resectable Distal MetastasisNot yet recruitingNCT05359393Phase 2
- Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver MetastasisNot yet recruitingNCT05354674
- Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine NeoplasmsNot yet recruitingNCT05316480Phase 2
- ZR-CHOP in DLBCL With Specific Gene AbnormalityRecruitingNCT05290337Phase 2
- Pembrolizumab Plus Chemo in Neoadjuvant Treatment of Esophageal Squamous Cell Carcinoma (Eastern Cooperative Thoracic Oncology Projects 2004, ECTOP-2004)RecruitingNCT05281003Phase 2
- R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS RelapseRecruitingNCT05257018Phase 2
- Parsaclisib in Combination With CHOP in Participants With Previously Untreated PTCLNot yet recruitingNCT05238064Phase 1/2
- Irinotecan Plus Anlotinib or Further in Combination With Penpulimab for Second-line Treatment of mCRCRecruitingNCT05229003Phase 2
- Immune Therapy in HR-positive/HER2-negative Metastatic Breast Cancer(ENIGMA)-BCTOP-L-M02RecruitingNCT05205200Phase 2
- Neoadjuvant FOLFOXIRI Versus CapeOX Chemotherapy for Local Advanced Rectal CancerRecruitingNCT05201430Phase 3
- Cryoablation Combined with Sintilimab Plus Lenvatinib in Previously Treated Unresectable Liver Metastasis from Solid TumorsRecruitingNCT05098847Phase 2
- Anatomical Location and Metastasis Pattern of Intrapulmonary Lymph Nodes in NSCLC (ECTOP-1010)RecruitingNCT05094882
- Thymosin-alpha 1 for Adjuvant Treatment After Radical Resection of High-risk Stage II and III Colorectal CancerRecruitingNCT05086614Phase 3
- Reverse Triple Negative Immune Resistant Breast CancerRecruitingNCT05076682Phase 2
- Medial vs. Entire Supraclavicular Lymph Node Radiation Therapy for Patients With Invasive Breast CancerRecruitingNCT05059379Phase 3
- Cryoablation Combined with Tislelizumab Plus Lenvatinib As Second-line or Later Therapy in Advanced Hepatocellular CarcinomaRecruitingNCT05057845Phase 2
- Cryoablation Combined with Sintilimab Plus Regorafenib in Previously Treated Colorectal Cancer Liver MetastasisRecruitingNCT05057052Phase 2
- The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer PatientsRecruitingNCT05032768
- Lenvatinib Plus Sintilimab in Patients with Immune Checkpoint Inhibitor Previously Treated Advanced Liver CancerRecruitingNCT05010681Phase 2
- Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaRecruitingNCT04997837Phase 3
- Long-term Survivorship of Discharged Patients With Malignant Tumor Based on Single-institutional Cancer RegistryRecruitingNCT04996732
- Induction Chemotherapy and Toripalimab for Larynx Preservation in Resectable Laryngeal/Hypopharyngeal CarcinomaRecruitingNCT04995120Phase 2
- Fluzoparib and Camrelizumab in Treating Patients With R/M NPC That Progressed After First-line ChemotherapyRecruitingNCT04978012Phase 2
- TACE Combined with Tislelizumab in Patients with Advanced Intrahepatic CholangiocarcinomaRecruitingNCT04954781Phase 2
- Single Arm Phase II Study of Fractionated Stereotatic Radiation Therapy (FSRT) for Bone Metastases in Breast CancerRecruitingNCT04947280Phase 1/2
- Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)Not yet recruitingNCT04922008Phase 2
- CTC vs Radiography as the Evidence of Recurrence in Colorectal Cancer PatientsNot yet recruitingNCT04917289Phase 3
- Treatment Response Prediction System of mCRC Patients Based on CTCNot yet recruitingNCT04917276
- Prognosis Predicting of CRC Patients Based on Morphology and Molecular Biomaker of CTCNot yet recruitingNCT04912882
- Toripalimab Based Induction Chemotherapy Followed by De-escalation Protocols in HPV-related OPSCCRecruitingNCT04867330Not applicable
- Laparoscopic Versus Open Pancreatoduodenectomy Following Neoadjuvant Chemotherapy for BRPCRecruitingNCT04855331Not applicable
- FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver MetastasesRecruitingNCT04832776Phase 2
- Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical StudyNot yet recruitingNCT04831528